| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.22 | 0.04 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.12 | 0.7 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0008 |